Bristol-Myers Squibb Co.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $39.61B | $35.95B | $13.98B |
| FY2022 | $35.06B | $31.06B | $9.12B |
| FY2023 | $36.65B | $29.43B | $11.46B |
| FY2024 | $47.60B | $16.34B | $10.35B |
| FY2025 | $42.85B | $18.47B | $10.21B |